Single-center, double-blinded, randomized, controlled safety and feasibility pilot study of
high dose IV ascorbic acid (200mg/kg) over 24 hours, divided into four doses and administered
every six hours with a 30 minute IV infusion time per dose, compared to matched placebo
infusion